Posted:
9/13/2024, 8:08:16 AM
Location(s):
Massachusetts, United States ⋅ Cambridge, Massachusetts, United States
Experience Level(s):
Senior
Field(s):
AI & Machine Learning
Workplace Type:
Hybrid
Flagship Labs 101 (FL101) is a privately held, early-stage company building an experimental and computational discovery platform focused on cellular interactions. This is a unique opportunity to be at the forefront of scientific innovation, as we leverage cutting-edge advancements in machine learning to drive breakthroughs in drug discovery enabled by proprietary data-generation technology.
About Flagship
Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. Many of the companies Flagship has founded have addressed humanity’s most urgent challenges: vaccinating billions of people against COVID-19, curing intractable diseases, improving human health, preempting illness, and feeding the world by improving the resiliency and sustainability of agriculture. Flagship has been recognized twice on FORTUNE’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies, and has been twice named to Fast Company’s annual list of the World’s Most Innovative Companies. Learn more about Flagship at www.flagshippioneering.com.
Position Summary:
We are seeking a motivated and experienced Senior Computational Scientist to join our innovative team at Flagship Labs 101 (FL101). In this pivotal role, you will have the opportunity to apply your expertise in computational biology to develop novel methodologies and algorithms, furthering our understanding of complex biological systems. As part of our mission-driven team, you'll contribute your quantitative and computational skills to reveal novel and differentiated targets in a variety of disease areas. This role offers the opportunity to significantly influence our scientific and technical trajectory, working in a dynamic, early-stage environment in close collaboration with experimental scientists.
Key Responsibilities:
Qualifications:
Preferred Qualifications:
Why Join Us?
FL101 offers you a unique opportunity to:
Values and Behaviors:
Flagship is an experiment in institutional, entrepreneurial, and innovation practiced in the context of a small company with an insurgent mindset. We are seeking individuals with an entrepreneurial spirit, strong communication skills, and comfort in working in and contributing to a dynamic and cross-functional team environment. The level of the role will be commensurate with the education and years of experience of the identified candidates.
At Flagship, we recognize there is no perfect candidate. If you have some of the experience listed above but not all, please apply anyway. Experience comes in many forms, skills are transferable, and passion goes a long way. We are dedicated to building diverse and inclusive teams and look forward to learning more about your unique background.
Recruitment & Staffing Agencies: Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.
Website: https://www.flagshippioneering.com/
Headquarter Location: Cambridge, Massachusetts, United States
Employee Count: 5001-10000
Year Founded: 2000
Industries: Biotechnology ⋅ Business Development ⋅ Finance ⋅ Health Care ⋅ Venture Capital